We have provided evidence that NLRP6-deficient mice have altered intestinal antibody titers and this most likely contributes to the modulation of the gut microbiota, such as by antibody-coating of microbiota, known to have important implications in autoimmunity, including type 1 diabetes (52, 53). The gene discussed is NLRP6; the disease is type 1 diabetes mellitus.